Ionis Pharmaceuticals Inc (IONS)
Ionis announces Biogen to advance salanersen into SMA registrational studies based on positive interim Phase 1 results
Ionis announces Biogen to advance salanersen into SMA registrational studies based on positive interim Phase 1 results
There are no comments here yet...